Earnings Call · Q1 FY2025·2025-05-06

Q1 25EPS -100.00%*·Rev n/aQ4 24EPS -7.78%·Rev n/aQ3 24EPS +67.57%·Rev n/aQ2 24EPS -6.38%·Rev n/a⚠ consensus missing

Sarepta Therapeutics, Inc. SRPT

Mary Jenkins — Associate Director, Investor Relations

Doug Ingram — President and Chief Executive Officer

Dallan Murray — Chief Commercial Officer

Louise Rodino-Klapac — Chief Scientific Officer

Ian Estepan — Chief Financial Officer

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SRPT calls or request research access.

More SRPT calls Browse calls Request research access